Sign in

CIK 0000873303

  • Large accelerated filer

Sarepta Therapeutics, Inc.

Sign in to watch
Ticker
SRPT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
930797222
Phone
+1 617-274-4000
Business address
215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, 02142
Former names
Sarepta Therapeutics, Inc., AVI BIOPHARMA INC, ANTIVIRALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2018-03-15 Cumbo Alexander SVP, Chief Commercial Officer Exercise or conversion · Stock option (right to buy) −1,370 11,415
2018-03-15 Mahatme Sandesh EVP, CFO & CBO Exercise or conversion +2,500 $23.85 $60K 43,395
2018-03-15 Mahatme Sandesh EVP, CFO & CBO Shares withheld for taxes −734 $81.22 $60K 42,661
2018-03-15 Mahatme Sandesh EVP, CFO & CBO Exercise or conversion · Stock option (right to buy) −2,500 11,768
2018-03-05 Wigzell Hans Lennart Rudolf Director Grant or award +3,418 10,084
2018-03-05 Wigzell Hans Lennart Rudolf Director Grant or award · Stock option (right to buy) +4,820 4,820
2018-03-05 Ruff Shamim SVP, Chief Regulatory Affairs Grant or award · Stock option (right to buy) +70,000 70,000
2018-03-05 Nicaise Claude Director Grant or award +3,418 5,418
2018-03-05 Nicaise Claude Director Grant or award · Stock option (right to buy) +4,820 4,820
2018-03-05 Mahatme Sandesh EVP, CFO & CBO Grant or award · Stock option (right to buy) +97,500 97,500
2018-03-05 Howton David T SVP, General Counsel Grant or award · Stock option (right to buy) +70,000 70,000
2018-03-05 Cumbo Alexander SVP, Chief Commercial Officer Grant or award · Stock option (right to buy) +70,000 70,000
2018-03-05 BONNEY MICHAEL W Director Grant or award +3,418 3,418
2018-03-05 BONNEY MICHAEL W Director Grant or award · Stock option (right to buy) +4,820 4,820
2018-03-05 BEHRENS M KATHLEEN Director Grant or award +3,418 116,534
2018-03-05 BEHRENS M KATHLEEN Director Grant or award · Stock option (right to buy) +4,820 4,820
2018-03-05 Basi Guriqbal S. SVP, Chief Scientific Officer Grant or award · Stock option (right to buy) +70,000 70,000
2018-03-05 Barry Richard Director Grant or award +3,418 3,245,432
2018-03-05 Barry Richard Director Grant or award · Stock option (right to buy) +4,820 4,820
2017-12-04 BONNEY MICHAEL W Director Grant or award · Non-Qualified Stock Options (right to buy) +16,400 16,400

Page 37 of 38 · 760 trades